tm logo

Monitor this mark

View On USPTO

ERBITUX CETUXIMAB
Live/Registered
REGISTERED AND RENEWED

on 19 Nov 2017

Last Applicant/ Owned by

ImClone LLC

450 East 29th Street

New York

NY

10016

Serial Number

76670452 filed on 18th Dec 2006

Registration Number

3333263 registered on 13th Nov 2007

in the Principal Register

Correspondent Address

Bruce W. Longbottom

Bruce W. Longbottom

Lilly Corporate Center

Indianapolis, IN 46285

Filing Basis

1. use application currently

Disclaimer

NO DATA

ERBITUX CETUXIMAB

PHARMACEUTICAL PREPARATION, NAMELY MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER

Classification Information

Class [005]
Pharmaceutical Products

PHARMACEUTICAL PREPARATION, NAMELY MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER

First Use Date in General

19th Feb 2004

First Use Date in Commerce

19th Feb 2004

Mark Details

Serial Number

No 76670452

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.17.06 -

Diagonal line(s), band(s) or bar(s)

26.17.12 -

Chevrons and angles

Legal History

Show more

Status DateAction Taken
19th Nov 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
19th Nov 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
19th Nov 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
19th Nov 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23rd Oct 2017TEAS SECTION 8 & 9 RECEIVED
13th Nov 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
22nd Nov 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
22nd Nov 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
21st Nov 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08th Nov 2013REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED